Unbound MEDLINE

The effect of cetrorelix vs. ganirelix on pregnancy outcome using minimal gonadotropin stimulation in women with elevated day 3 serum follicle stimulating hormone levels. Clinical and experimental obstetrics & gynecology [Clin Exp Obstet Gynecol] Journal article

 
TitleThe effect of cetrorelix vs. ganirelix on pregnancy outcome using minimal gonadotropin stimulation in women with elevated day 3 serum follicle stimulating hormone levels.
Author(s)Check JH, Brasile D, Choe JK, Amui J, Wilson C 
InstitutionThe University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ, USA. laurie@ccivf.com
SourceClin Exp Obstet Gynecol 2009; 36(3):148-9.
AbstractPURPOSE: To determine if the choice of gonadotropin releasing hormone antagonist influences subsequent pregnancy rates in women with diminished egg reserve.
METHOD: Retrospective determination of pregnancy rates following embryo transfer in women with day 3 FSH >12 mIU/ml using lower dose gonadotropin stimulation regimen.
RESULTS: Though no significant differences were found there was a trend for lower pregnancy rates with ganirelix vs cetrorelix.
CONCLUSIONS: The trend for lower pregnancy rates with ganirelix vs. cetrorelix seen in women with diminished egg reserve is consistent with the findings of a study performed in women with normal egg reserve using a normal gonadotropin stimulation regimen. It is not clear if the adverse effect is on the endometrium or the embryo.
Languageeng
Pub Type(s)Journal Article
PubMed ID19860353
  
Advertise on this site.